Publications

Here's an overview of our selected publications.

Pasireotide as first line medical therapy for selected patients with acromegaly. Olarescu NC, Jørgensen AP, Atai S, Wiedmann MKH, Dahlberg D, Bollerslev J, Heck A.Pituitary. 2025 Apr 11;28(3):48. doi: 10.1007/s11102-025-01514-3. PMID: 40216609
Long-term depot specific changes in adipose tissue after treatment of acromegaly. Falch CM, Godang K, Lekva T, Ueland T, Heck A, Bollerslev J, Olarescu NC.Eur J Endocrinol. 2024 Mar 2;190(3):K37-K42. doi: 10.1093/ejendo/lvae016. PMID: 38401530
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours. Kolnes AJ, Øystese KAB, Sjöstedt E, Olarescu NC, Heck A, Pahnke J, Dahlberg D, Berg-Johnsen J, Ringstad G, Casar-Borota O, Bollerslev J, Jørgensen AP.Pituitary. 2023 Apr;26(2):227-236. doi: 10.1007/s11102-023-01310-x. PMID: 36952069
Trends in incidence and mortality risk for acromegaly in Norway: a cohort study. Falch CM, Olarescu NC, Bollerslev J, Dekkers OM, Heck A.Endocrine. 2023 Apr;80(1):152-159. doi: 10.1007/s12020-022-03275-6. Epub 2022 Dec 16. PMID: 36525222
Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation. Pretorius M, Lundstam K, Heck A, Fagerland MW, Godang K, Mollerup C, Fougner SL, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Bollerslev J.Ann Intern Med. 2022 Jun;175(6):812-819. doi: 10.7326/M21-4416. Epub 2022 Apr 19. PMID: 35436153
MANAGEMENT OF ENDOCRINE DISEASE: Individualised management of acromegaly Bollerslev J, Heck A, Olarescu NC Eur J Endocrinol. 2019 Aug;181(2):R57-R71. doi: 10.1530/EJE-19-0124.
PCSK1N as a Tumor Size Marker and an ER Stress Response Protein in Corticotroph Pituitary Adenomas Abusdal M, Normann KR, Nyman TA, Øystese KAO, Sundaram AYM, Dahlberg D, Lekva T, Bollerslev J, Berg JP, Olarescu NC J Clin Endocrinol Metab. 2025 Mar 17;110(4):1065-1075. doi: 10.1210/clinem/dgae643.

Published June 10, 2025 10:45 AM - Last modified June 10, 2025 10:45 AM